Consensus Cencora, Inc.

Stocks

COR

US03073E1055

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 21:00:03 16/10/2026 BST			5-day change	1st Jan Change
340.92 ^USD	-0.14%		+5.27%	+0.94%

10-16	UBS Adjusts Price Target on Cencora to $400 From $430, Keeps Buy Rating	MT
10-12	Baird Adjusts Price Target on Cencora to $373 From $370	MT

Evolution of the Average Target: Cencora, Inc.

Evolution of the Target Price: Cencora, Inc.

Changes in Analyst Recommendations: Cencora, Inc.

e66c28de.h0Z2s6TinwflEg1OM5ljj1Rylt8jHop-7VJSmJwIlSw.9SUunuCD5UCxRUsEVOEV9h0i5rdtbsMrmQ027Ptt3UrmAgHBktPacoZmSA~518143a7cf49063c37c259f0888b9003

Analysts' recommendations: Cencora, Inc.

10-16	UBS Adjusts Price Target on Cencora to $400 From $430, Keeps Buy Rating	MT
10-12	Baird Adjusts Price Target on Cencora to $373 From $370	MT
10-07	Leerink Partners Adjusts Price Target on Cencora to $388 From $380	MT
08-19	RBC Initiates Cencora at Sector Perform With $330 Price Target	MT
08-11	Wells Fargo Adjusts Price Target on Cencora to $395 From $331, Keeps Overweight Rating	MT
08-07	JPMorgan Adjusts Price Target on Cencora to $390 From $382	MT
08-06	Citigroup Adjusts Price Target on Cencora to $370 From $355	MT
08-06	Leerink Partners Adjusts Price Target on Cencora to $380 From $368	MT
08-06	Evercore ISI Adjusts Price Target on Cencora to $350 From $330	MT
08-06	Baird Adjusts Price Target on Cencora to $370 From $340	MT
08-06	UBS Adjusts Price Target on Cencora to $430 From $412, Maintains Buy Rating	MT
07-22	Baird Adjusts Price Target on Cencora to $340 From $337, Maintains Outperform Rating	MT
07-21	BofA Securities Adjusts Cencora Price Target to $310 From $285	MT
07-07	Evercore ISI Adjusts Price Target on Cencora to $330 From $300	MT
06-24	Argus Adjusts Price Target on Cencora to $340 From $4000, Maintains Buy Rating	MT
06-24	BofA Adjusts Price Target on Cencora to $285 From $280	MT
06-10	Barclays Cuts Cencora Price Target to $350 From $425, Maintains Overweight Rating	MT
05-21	Baird Adjusts Price Target on Cencora to $337 From $339, Maintains Outperform Rating	MT
05-11	Wells Fargo Adjusts Price Target on Cencora to $331 From $429	MT
05-08	McKesson's Fiscal 2027 Guidance 'Encouraging,' Cencora Selloff Overdone, Morgan Stanley Says	MT
05-08	Morgan Stanley Lowers Price Target on Cencora to $342 From $400, Keeps Overweight Rating	MT
05-07	UBS Adjusts Price Target on Cencora to $412 From $410, Maintains Buy Rating	MT
04-28	William Blair Initiates Cencora at Market Perform	MT
04-08	Evercore ISI Adjusts Price Target on Cencora to $360 From $420, Maintains Outperform Rating	MT
03-19	Baird Adjusts Price Target on Cencora to $420 From $415, Maintains Outperform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CENCORA, INC.					+7.85%
	ABBOTT LABORATORIES					+15.09%
	MEDTRONIC PLC					+10.41%
	STRYKER CORPORATION					+23.06%
	ESSILORLUXOTTICA					+43.42%
	HOYA CORPORATION					+17.74%
	BECTON, DICKINSON AND COMPANY					+1.21%
	IDEXX LABORATORIES, INC.					+25.9%
	DEXCOM, INC.					+12.11%
	ALCON INC.					+36.63%
	Average					+19.34%
	Weighted average by Cap.					+18.51%